D-201-2013 Class III Terminated
FDA drug recall D-201-2013 was initiated by West-Ward Pharmaceutical Corp. on Nov 30, 2012 and is designated Class III. Reason for recall: Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled… The recall status is terminated (terminated Dec 18, 2014). Affected quantity: 1763 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2013
- Initiation Date
- Nov 30, 2012
- Termination Date
- Dec 18, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1763 bottles
Product description
Carisoprodol Tablets, USP, 350 mg Rx Only, 100 tablets per bottle, Rx Only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724, NDC 0143-1176-01.
Reason for recall
Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance. This product is being recalled because this controlled product was not relabeled with the required "C-IV" imprint on the label for products distributed after the 06/11/12 deadline.
Distribution pattern
Nationwide
Code information
Lot #: 69160A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-201-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026